Does RISANKIZUMAB-RZAA Cause Sars-cov-2 test positive? 335 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 335 reports of Sars-cov-2 test positive have been filed in association with RISANKIZUMAB-RZAA. This represents 0.5% of all adverse event reports for RISANKIZUMAB-RZAA.
335
Reports of Sars-cov-2 test positive with RISANKIZUMAB-RZAA
0.5%
of all RISANKIZUMAB-RZAA reports
5
Deaths
68
Hospitalizations
How Dangerous Is Sars-cov-2 test positive From RISANKIZUMAB-RZAA?
Of the 335 reports, 5 (1.5%) resulted in death, 68 (20.3%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Sars-cov-2 test positive Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 335 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Sars-cov-2 test positive?
OCRELIZUMAB (1,421)
ADALIMUMAB (1,301)
DUPILUMAB (860)
NIRMATRELVIR\RITONAVIR (538)
LENALIDOMIDE (469)
SECUKINUMAB (378)
CERTOLIZUMAB PEGOL (361)
RITUXIMAB (305)
UPADACITINIB (281)
INFLIXIMAB (269)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Sars-cov-2 test positive Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA